| scholarly article | Q13442814 |
| P50 | author | Mark Pepys | Q6769213 |
| Martino Bolognesi | Q28036824 | ||
| Stefano Ricagno | Q41086038 | ||
| Sophie Valleix | Q41132513 | ||
| Pierre Lozeron | Q51697645 | ||
| Brigitte Nedelec | Q57313224 | ||
| V Bellotti | Q72990986 | ||
| Jean-Michel Goujon | Q96198119 | ||
| P2093 | author name string | David Adams | |
| Marc Delpech | |||
| Ahmet Dogan | |||
| Julian D Gillmore | |||
| Philip N Hawkins | |||
| Sofia Giorgetti | |||
| Violaine Planté-Bordeneuve | |||
| Jason D Theis | |||
| Julie A Vrana | |||
| Thierry Maisonobe | |||
| Guy Touchard | |||
| Frank Bridoux | |||
| Monica Stoppini | |||
| Riccardo Porcari | |||
| Catherine Lacroix | |||
| Corinne Lacombe | |||
| Palma P Mangione | |||
| Mathieu Boimard | |||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | AL amyloidosis | Q4652470 |
| P304 | page(s) | 2276-2283 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin | |
| P478 | volume | 366 |
| Q40484665 | A covalent homodimer probing early oligomers along amyloid aggregation |
| Q38333529 | A new prion disease: relationship with central and peripheral amyloidoses |
| Q35456927 | A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred |
| Q35165212 | A simulated intermediate state for folding and aggregation provides insights into ΔN6 β2-microglobulin amyloidogenic behavior |
| Q33587678 | A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo. |
| Q40117218 | A systematic molecular dynamics approach to the structural characterization of amyloid aggregation propensity of β2-microglobulin mutant D76N. |
| Q46330754 | A tale of two tails: The importance of unstructured termini in the aggregation pathway of β2-microglobulin. |
| Q38809423 | Advances in proteomic study of cardiac amyloidosis: progress and potential. |
| Q36493200 | Amyloid neuropathies |
| Q51039676 | An Asp to Asn mutation is a toxic trigger in beta-2 microglobulin: structure and biophysics. |
| Q41837825 | An imaging and systems modeling approach to fibril breakage enables prediction of amyloid behavior |
| Q42688779 | An in vivo platform for identifying inhibitors of protein aggregation |
| Q48058836 | Assessing the effect of D59P mutation in the DE loop region in amyloid aggregation propensity of β2-microglobulin: A molecular dynamics simulation study. |
| Q42224616 | Benzalkonium chloride accelerates the formation of the amyloid fibrils of corneal dystrophy-associated peptides |
| Q47722422 | Biophysical Aspects of Alzheimer's Disease: Implications for Pharmaceutical Sciences : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla |
| Q35134538 | C-terminal sequence of amyloid-resistant type F apolipoprotein A-II inhibits amyloid fibril formation of apolipoprotein A-II in mice. |
| Q27325393 | C. elegans expressing human β2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype |
| Q40826378 | Capillary electrophoresis analysis of different variants of the amyloidogenic protein β2 -microglobulin as a simple tool for misfolding and stability studies |
| Q47948462 | Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulin. |
| Q27680885 | Class I Major Histocompatibility Complex, the Trojan Horse for Secretion of Amyloidogenic β 2 -Microglobulin |
| Q48595869 | Clinical characteristics and SAP scintigraphic findings in 10 patients with AGel amyloidosis |
| Q33828590 | Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics |
| Q36850057 | Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS. |
| Q55191641 | Conformational dynamics in crystals reveal the molecular bases for D76N beta-2 microglobulin aggregation propensity. |
| Q36528525 | D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile |
| Q35857382 | Decoding the Structural Bases of D76N ß2-Microglobulin High Amyloidogenicity through Crystallography and Asn-Scan Mutagenesis |
| Q35558791 | Energy landscapes of functional proteins are inherently risky |
| Q36666286 | Expanding the repertoire of amyloid polymorphs by co-polymerization of related protein precursors |
| Q34401190 | FAP neuropathy and emerging treatments |
| Q92826292 | Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease |
| Q26744469 | Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue Targeting |
| Q38970608 | Immunoglobulin Light Chain Systemic Amyloidosis |
| Q42319844 | Influence of heparin molecular size on the induction of C- terminal unfolding in β2-microglobulin |
| Q61813463 | Investigating the Molecular Basis of the Aggregation Propensity of the Pathological D76N Mutant of Beta-2 Microglobulin: Role of the Denatured State |
| Q90133267 | Loosening of Side-Chain Packing Associated with Perturbations in Peripheral Dynamics Induced by the D76N Mutation of β2-Microglobulin Revealed by Pressure-NMR and Molecular Dynamic Simulations |
| Q38223686 | Misfolding of amyloidogenic proteins and their interactions with membranes |
| Q37117146 | Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2-microglobulin |
| Q38771098 | Molecular pathogenesis of human amyloidosis: Lessons from β2 -microglobulin-related amyloidosis |
| Q36929132 | Monitoring the interaction between β2-microglobulin and the molecular chaperone αB-crystallin by NMR and mass spectrometry: αB-crystallin dissociates β2-microglobulin oligomers. |
| Q37067700 | Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro. |
| Q47590416 | Online registry for mutations in hereditary amyloidosis including nomenclature recommendations |
| Q38131710 | Pathophysiology and treatment of systemic amyloidosis |
| Q92641674 | Possible mechanisms of polyphosphate-induced amyloid fibril formation of β2-microglobulin |
| Q27681502 | Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis |
| Q26776392 | Proteomics and mass spectrometry in the diagnosis of renal amyloidosis |
| Q41085989 | Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability |
| Q38935425 | Recent advances in the noninvasive strategies of cardiac amyloidosis |
| Q64938055 | Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy. |
| Q43127628 | Structural and Thermodynamic Characteristics of Amyloidogenic Intermediates of β-2-Microglobulin |
| Q27679310 | Structure of an early native-like intermediate of β2-microglobulin amyloidogenesis |
| Q37312131 | Structure, folding dynamics, and amyloidogenesis of D76N β2-microglobulin: roles of shear flow, hydrophobic surfaces, and α-crystallin. |
| Q30251986 | Systemic amyloidosis |
| Q30372510 | Systemic amyloidosis: lessons from β2-microglobulin. |
| Q57159243 | Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms |
| Q92642050 | The Early Phase of β2m Aggregation: An Integrative Computational Study Framed on the D76N Mutant and the ΔN6 Variant |
| Q36709380 | The Implication and Significance of Beta 2 Microglobulin: A Conservative Multifunctional Regulator |
| Q57787220 | The structure of a β2-microglobulin fibril suggests a molecular basis for its amyloid polymorphism |
| Q48093443 | VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants |
| Q35585323 | Wild type beta-2 microglobulin and DE loop mutants display a common fibrillar architecture |
| Q28541669 | β2-Microglobulin amyloid fibril-induced membrane disruption is enhanced by endosomal lipids and acidic pH |
Search more.